Quantification of T-cell-mediated apoptosis in heterogeneous leukemia populations using four-color multiparameter flow cytometry

Cytometry Part A

Volumn 66, Issue 1, 2005, Pages 71-77

  Westers, Theresia M ^a   Houtenbos, Ilse ^a   Schuurhuis, Gerrit Jan ^a   Ossenkoppele, Gert J ^a   Van De Loosdrecht, Arjan A ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

7 aminoactinomycine D; Apoptosis; Cytotoxicity; Flow cytometry; Immunotherapy; Leukemia; SYTO16

Indexed keywords

7 AMINODACTINOMYCIN; CELL MARKER; FLUORESCENT DYE; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; ARTICLE; CELL DEATH; CELL HETEROGENEITY; CELL LINE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; STAINING; T LYMPHOCYTE; VALIDATION PROCESS;

ANTIGENS, CD28; APOPTOSIS; CELL DEATH; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DACTINOMYCIN; FLOW CYTOMETRY; FLUORESCENT DYES; HL-60 CELLS; HUMANS; K562 CELLS; LEUKEMIA, MYELOCYTIC, ACUTE; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL; U937 CELLS;

EID: 20944452322     PISSN: 15524922     EISSN: None     Source Type: Journal    
DOI: 10.1002/cyto.a.20146     Document Type: Article

References (22)

1. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 1968;14:181-196.
2. Goldberg JE, Sherwood SW, Clayberger C. A novel method for measuring CTL and NK cell-mediated cytotoxicity using annexin V and two-color flow cytometry. J Immunol Methods 1999;224:1-9.
3. King MA. Detection of dead cells and measurement of cell killing by flow cytometry. J Immunol Methods 2000;243:155-166.
4. Godoy-Ramirez K, Franck K, Gaines H. A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J Immunol Methods 2000;239:35-44.
5. Lecoeur H, Fevrier M, Garcia S. Riviere Y, Gougeon ML. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 2001;253:177-187.
6. Fischer K, Andreesen R, Mackensen A. An improved flow cytometric assay for the determination of cytotoxic T lymphocyte activity. J Immunol Methods 2002;259:159-169.
7. Marin L, Minguela A, Torio A, Moya-Quiles MR, Muro M, Montes-Ares O, Parrado A, Alvarez-Lopez DM, Garcia-Alonso AM. Flow cytometric quantification of apoptosis and proliferation in mixed lymphocyte culture. Cytometry 2003;51A:107-118.
8. Hoppner M, Luhm J, Schlenke P, Koritke P, Frohn C. A flow-cytometry based cytotoxicity assay using stained effector cells in combination with native target cells. J Immunol Methods 2002;267:157-163.
9. Jedema I, Van Der Werff NM, Barge RM, Willemze R, Falkenburg JH. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 2004;103:2677-2682.
10. van der Pol MA, Pater JM, Feller N, Westra AH, van Stijn A, Ossenkoppele GJ, Broxterman HJ, Schuurhuis GJ. Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia. Leukemia 2001;15:1554-1563.
11. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003;3:361-370.
12. Trambas CM, Griffiths GM. Delivering the kiss of death. Nat Immunol 2003;4:399-403.
13. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002;100: 2292-2302.
14. Westers TM, Stam AG, Scheper RJ, Regelink JC, Nieuwint AW, Schuurhuis GJ, van de Loosdrecht AA, Ossenkoppele GJ. Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia. Cancer Immunol Immunother 2003;52:17-27.
15. Houtenbos I, Westers TM, Stam AG, De Gruijl TD, Scheper RJ, Ossenkoppele GJ, van de Loosdrecht AA. Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation. Cancer Immunol Immunother 2003;52:455-462.
16. Schuurhuis GJ, Muijen MM, Oberink JW, de Boer F, Ossenkoppele GJ, Broxterman HJ. Large populations of non-clonogenic early apoptotic CD34-positive cells are present in frozen-thawed peripheral blood stem cell transplants. Bone Marrow Transplant 2001;27:487-498.
17. Ossenkoppele GJ, Stam AG, Westers TM, De Gruijl TD, Janssen JJ, van de Loosdrecht AA, Scheper RJ. Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cells. Leukemia 2003;17:1424-1426.
18. Vermes I, Haanert C, Reutelingsperger C. Flow cytometry of apoptotic cell death. J Immunol Methods 2000;243:167-190.
19. van der Pol MA, Broxterman HJ, Westra G, Ossenkoppele GJ, Schuurhuis GJ. Novel multiparameter flow cytometry assay using Sytolo for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples. Cytometry 2003; 55B:14-21.
20. Keeney M, Chin-Yee I, Weir K, Popma J, Nayar R, Sutherland DR. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 1998;34:61-70.
21. Molldrem JJ, Lee PP, Wang C, Felio K, Kantarjian HM, Champlin RE, Davis MM. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat Med 2000;6: 1018-1023.
22. Hirst W, Buggins A, Mufti G. Central role of leukemia-derived factors in the development of leukemia-associated immune dysfunction. Hematol J 2001;2:2-17.